Cargando…
Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
Equitable access to medicines has played a vital role to improve patient health outcomes and reducing mortality globally. However, it is important to note that medicines pricing is a key determinant in promoting access to medicines. The studies and empirical data have shown that there are wide varia...
Autor principal: | Babar, Zaheer-Ud-Din |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867617/ https://www.ncbi.nlm.nih.gov/pubmed/35209945 http://dx.doi.org/10.1186/s40545-022-00413-3 |
Ejemplares similares
-
Ten recommendations to improve pharmacy practice in low and middle-income countries (LMICs)
por: Babar, Zaheer-Ud-Din
Publicado: (2021) -
A leap towards enforcing medicines prescribing by generic names in low- and middle-income countries (LMICs): pitfalls, limitations, and recommendations for local drug regulatory agencies
por: Merchant, Hamid A., et al.
Publicado: (2022) -
The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2019) -
Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature
por: Ocran Mattila, Phyllis, et al.
Publicado: (2021) -
COVID-19 vaccines pricing policy options for low-income and middle- income countries
por: Guzman, Javier, et al.
Publicado: (2021)